These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 9034226)
1. Renal disposition of recombinant human interleukin-11 in the isolated perfused rat kidney. Takagi A; Yabe Y; Oka Y; Sawai K; Takakura Y; Hashida M Pharm Res; 1997 Jan; 14(1):86-90. PubMed ID: 9034226 [TBL] [Abstract][Full Text] [Related]
2. Hepatic disposition characteristics of recombinant human interleukin-11 (rhIL-11) in the perfused rat liver. Takagi A; Yabe Y; Yoshida M; Takakura Y; Hashida M Biol Pharm Bull; 1998 Dec; 21(12):1364-6. PubMed ID: 9881656 [TBL] [Abstract][Full Text] [Related]
3. Disposition characteristics of protein drugs in the perfused rat kidney. Mihara K; Hojo T; Fujikawa M; Takakura Y; Sezaki H; Hashida M Pharm Res; 1993 Jun; 10(6):823-7. PubMed ID: 8321849 [TBL] [Abstract][Full Text] [Related]
4. Disposition characteristics of recombinant human interleukin-11 after a bolus intravenous administration in mice. Takagi A; Masuda H; Takakura Y; Hashida M J Pharmacol Exp Ther; 1995 Nov; 275(2):537-43. PubMed ID: 7473136 [TBL] [Abstract][Full Text] [Related]
5. Disposition characteristics of model macromolecules in the perfused rat kidney. Mihara K; Mori M; Hojo T; Takakura Y; Sezaki H; Hashida M Biol Pharm Bull; 1993 Feb; 16(2):158-62. PubMed ID: 7689886 [TBL] [Abstract][Full Text] [Related]
6. Effect of co-administration of cationic macromolecules on the in vivo disposition and in situ renal disposition characteristics of rhIL-11. Takagi A; Yabe Y; Oka Y; Takakura Y; Hashida M Drug Metab Pharmacokinet; 2002; 17(2):136-41. PubMed ID: 15618662 [TBL] [Abstract][Full Text] [Related]
7. Renal disposition characteristics of oligonucleotides modified at terminal linkages in the perfused rat kidney. Sawai K; Miyao T; Takakura Y; Hashida M Antisense Res Dev; 1995; 5(4):279-87. PubMed ID: 8746777 [TBL] [Abstract][Full Text] [Related]
8. Disposition of oligonucleotides in isolated perfused rat kidney: involvement of scavenger receptors in their renal uptake. Sawai K; Mahato RI; Oka Y; Takakura Y; Hashida M J Pharmacol Exp Ther; 1996 Oct; 279(1):284-90. PubMed ID: 8859005 [TBL] [Abstract][Full Text] [Related]
9. Manipulation of renal disposition of human recombinant superoxide dismutase by chemical modification. Mihara K; Sawai K; Takakura Y; Hashida M Biol Pharm Bull; 1994 Feb; 17(2):296-301. PubMed ID: 7515745 [TBL] [Abstract][Full Text] [Related]
10. Kidney as a major clearance organ for recombinant human interleukin-1 receptor antagonist. Kim DC; Reitz B; Carmichael DF; Bloedow DC J Pharm Sci; 1995 May; 84(5):575-80. PubMed ID: 7658347 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of [125I]-recombinant human interleukin-11: 1. Absorption, distribution and excretion after subcutaneous administration to male rats. Uchida T; Aoyama K; Mori K; Usui T; Watanabe T; Takariki Y; Asahara N; Hirose M; Kimura T; Tateishi M; Higuchi S Eur J Drug Metab Pharmacokinet; 1998; 23(3):403-10. PubMed ID: 9842984 [TBL] [Abstract][Full Text] [Related]
12. Renal tubular handling of p-aminohippurate and epidermal growth factor (EGF) in filtering and nonfiltering perfused rat kidneys. Kim DC; Sugiyama Y; Sawada Y; Hanano M Pharm Res; 1992 Feb; 9(2):271-5. PubMed ID: 1553353 [TBL] [Abstract][Full Text] [Related]
13. Stimulation by interleukin-1 of renal calcium reabsorption in thyroparathyroidectomized rats. Caverzasio J; Rizzoli R; Vallotton MB; Dayer JM; Bonjour JP J Bone Miner Res; 1993 Oct; 8(10):1219-25. PubMed ID: 8256659 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of recombinant human interleukin-11 (rhIL-11) in healthy male subjects. Aoyama K; Uchida T; Takanuki F; Usui T; Watanabe T; Higuchi S; Toyoki T; Mizoguchi H Br J Clin Pharmacol; 1997 Jun; 43(6):571-8. PubMed ID: 9205816 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of [125I]-recombinant human interleukin-11: 2. Placental transfer and excretion into milk after subcutaneous administration to rats. Uchida T; Aoyama K; Mori K; Usui T; Watanabe T; Takariki Y; Asahara N; Hirose M; Kimura T; Tateishi M; Higuchi S Eur J Drug Metab Pharmacokinet; 1998; 23(3):411-6. PubMed ID: 9842985 [TBL] [Abstract][Full Text] [Related]
16. Comparative tissue distribution of 125I- and U-14C-labeled recombinant human interleukin-2 in the rat. Sabo J; Ni G; Nadeau R; Liberato DJ; Loh A Lymphokine Cytokine Res; 1992 Aug; 11(4):229-33. PubMed ID: 1420601 [TBL] [Abstract][Full Text] [Related]
17. Effect of acute renal failure on insulin disposition in the isolated perfused rat kidney. Brier ME; Aronoff GR; Mayer PR Am J Physiol; 1987 Nov; 253(5 Pt 2):F884-8. PubMed ID: 3318499 [TBL] [Abstract][Full Text] [Related]
18. Disposition of 4-methylbenzoylglycine in rat isolated perfused kidney and effects of hippurates on renal mitochondrial metabolism. Masereeuw R; Moons MM; Russel FG J Pharm Pharmacol; 1998 Dec; 50(12):1397-404. PubMed ID: 10052856 [TBL] [Abstract][Full Text] [Related]
19. In vitro comparison of renal handling and uptake of two somatostatin receptor-specific peptides labeled with indium-111. Trejtnar F; Novy Z; Petrik M; Laznickova A; Melicharova L; Vankova M; Laznicek M Ann Nucl Med; 2008 Dec; 22(10):859-67. PubMed ID: 19142704 [TBL] [Abstract][Full Text] [Related]
20. Differential disposition of intra-renal generated and preformed glucuronides: studies with 4-methylumbelliferone and 4-methylumbelliferyl glucuronide in the filtering and nonfiltering isolated perfused rat kidney. Wang J; Evans AM; Knights KM; Miners JO J Pharm Pharmacol; 2011 Apr; 63(4):507-14. PubMed ID: 21401602 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]